fbpx
April 13, 2022

Oxytocin and Social interaction Improve Symptoms in Autism Oxytocin and Social interaction Improve Symptoms in Autism

The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Novel reduced-dose intranasal oxytocin […]
April 12, 2022

Novel, Non–anti-amyloid Shows Early Promise in Alzheimer’s Novel, Non–anti-amyloid Shows Early Promise in Alzheimer’s

Scientists believe they have developed a drug that neutralizes a neurotoxic chemical in the brain that triggers the degenerative process leading to Alzheimer’s disease (AD). The […]
April 12, 2022

Long-Term Temozolomide in Patients With Glioblastoma Long-Term Temozolomide in Patients With Glioblastoma

The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. Key Takeaways Patients with glioblastoma (GBM) […]
April 12, 2022

Novel Antibody May Reduce Amyloid, Cut AD Symptoms Novel Antibody May Reduce Amyloid, Cut AD Symptoms

SEATTLE – An update from a phase 2 study – core and open-label extension – of lecanemab in Alzheimer’s disease showed that the antibody reduced amyloid […]
April 11, 2022

New Data Shed Light on Racial, Ethnic Diversity in MS New Data Shed Light on Racial, Ethnic Diversity in MS

SEATTLE – Multiple sclerosis (MS), sometimes thought of as primarily affecting Whites, is also common among Hispanic and Black people. These populations often have more severe disease, likely driven […]
April 11, 2022

Neuropathophysiological Indicators in ASD May Dissipate With Age Neuropathophysiological Indicators in ASD May Dissipate With Age

The study covered in this summary was published on MedRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways White matter aberration appears […]
April 11, 2022

Novel Drug Shows Promise as First-Line Parkinson’s Treatment Novel Drug Shows Promise as First-Line Parkinson’s Treatment

An experimental drug that combines fixed doses of extended-release (ER) formulations of existing medications can significantly reduce symptoms in patients with untreated early-stage Parkinson’s disease (PD), […]
April 11, 2022

Shift Work May Affect Working Memory and Processing Speed Shift Work May Affect Working Memory and Processing Speed

This article was originally published in German on Medscape. Shift work is associated with poor working memory and slower mental processing speed. This is the outcome […]
April 8, 2022

Novel Steroid Therapy May Counter Ataxia Telangiectasia Novel Steroid Therapy May Counter Ataxia Telangiectasia

SEATTLE — A novel therapy for ataxia telangiectasia that delivers dexamethasone sodium phosphate (DSP) through autologous red blood cells has shown promise in a phase 3 clinical trial. […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0